IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 455 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
  
 Resource links
   Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
   Article in PDF (3,907 KB)
   Citation Manager
   Access Statistics
   Reader Comments
   Email Alert *
   Add to My List *
* Registration required (free)  

 
  In this article
   References
   Article Figures

 Article Access Statistics
    Viewed1689    
    Printed32    
    Emailed0    
    PDF Downloaded60    
    Comments [Add]    

Recommend this journal

 


 
 Table of Contents    
LETTER TO THE EDITOR - THERAPY LETTER
Year : 2018  |  Volume : 84  |  Issue : 4  |  Page : 485-487

Cutaneous botryomycosis treated successfully with injectable ceftriaxone sodium in an immunocompetent child


1 Department of Dermatology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India
2 Department of Pathology, Prolife Diagnostics, Bhubaneswar, Odisha, India

Date of Web Publication08-Jun-2018

Correspondence Address:
Chandra Sekhar Sirka
Department of Dermatology, All India Institute of Medical Sciences, Bhubaneswar, Odisha
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijdvl.IJDVL_927_17

Rights and Permissions



How to cite this article:
Pradhan S, Sirka CS, Panda M, Baisakh M. Cutaneous botryomycosis treated successfully with injectable ceftriaxone sodium in an immunocompetent child. Indian J Dermatol Venereol Leprol 2018;84:485-7

How to cite this URL:
Pradhan S, Sirka CS, Panda M, Baisakh M. Cutaneous botryomycosis treated successfully with injectable ceftriaxone sodium in an immunocompetent child. Indian J Dermatol Venereol Leprol [serial online] 2018 [cited 2019 Oct 22];84:485-7. Available from: http://www.ijdvl.com/text.asp?2018/84/4/485/233969




Sir,

Botryomycosis is a chronic granulomatous suppurative bacterial infection.[1],[2] It is a rare and uncommon disease, mostly reported in immunocompromised adults. Approximately 200 patients have been reported in English literature.[3] Its occurrence in children is rare. We describe a case of cutaneous botryomycosis in an immunocompetent girl child treated successfully with injectable ceftriaxone sodium.

A 14-year-old girl presented to the dermatology outpatient department of All India Institute of Medical Sciences, Bhubaneswar with swellings on the right foot studded with papules and nodules on it for 3 years. She gave a history of trauma on the right foot. She had undergone incision and drainage of the swellings twice in the past with no significant improvement. Rather, she continued to develop papules and nodules on the swellings. Cutaneous examination revealed skin-colored lobulated swellings on the dorsum of the right foot with multiple skin-colored papules and nodules of varying stages with surface change like erosion, crusting and ulceration on papules and nodules and some giving serous and seropurulent discharge [Figure 1]a. Similar lesions were also present on the sole of the foot [Figure 1]b. Based on these clinical findings, botryomycosis, eumycetoma, actinomycetoma and actinomycosis were kept in differentials and the patient was investigated.
Figure 1

Click here to view


Her routine investigations were within normal limit. Test for human immunodeficiency virus by enzyme-linked immunosorbent assay was negative. X-ray of the right foot did not show any bony abnormalities. Tissue culture and pus culture showed methicillin-sensitive Staphylococcus aureus sensitive to amikacin and ceftriaxone. KOH and fungal culture of the seropurulent discharge did not reveal any organism. Biopsy of the nodule showed bacterial granules in dermis with an eosinophilic rim at the periphery suggestive of Splendore–Hoeppli phenomenon [Figure 2]. Based on clinical, microbiological and histopathological findings, the diagnosis of botryomycosis was made. Patient was initiated on injection ceftriaxone sodium 1,000 mg intravenous daily. After 2 and 1/2 months of treatment, the swelling subsided and nodules and papules disappeared completely [Figure 3]. The repeat complete hemogram, liver and renal function tests at the end of 2 months were normal. The patient had no side effects with ceftriaxone. Currently, the patient is under follow-up for 30 days with no recurrence.
Figure 2

Click here to view
Figure 3

Click here to view


The term botryomycosis was coined by Rivolta in 1884. The bacteria form granules deep in the tissue and resemble bunches of grapes (in Greek botrys), and mycosis; because it was thought to be fungal in origin. Later, in 1919, it was discovered to be of bacterial etiology.[4] Botryomycosis can be cutaneous and visceral. Cutaneous lesion account for 75% whereas rest is visceral form.[5]

Staphylococcus aureus is incriminated in 40% cases, followed by Pseudomonas aeruginosa 20%. Other organisms include coagulase-negative staphylococci, Streptococcus spp.,  Escherichia More Details coli and Proteus spp.[3] The predisposing factors include altered immune function and comorbid conditions such as diabetes mellitus, liver disease, alcoholism, lupus, cystic fibrosis, asthma, malnutrition, immunoglobulin deficiency, hyperglobulinemia E (Job syndrome), glomerulonephritis, treatment with corticosteroids and human immunodeficiency virus/acquired immunodeficiency syndrome.[6],[7] The local factors such as accident and postoperative skin trauma are also incriminated.[8]

It is believed that grouping and clustering (grains) of organism is responsible for resistance named as Splendore–Hoeppli phenomenon.[5],[8],[9] The Splendore–Hoeppli phenomenon represents presence of an antigen–antibody complex, tissue debris and fibrin that generate an eosinophilic matrix among bacterial granules in botryomycosis which prevents phagocytosis and intracellular destruction of the bacteria leading to chronic infection and thereby requires prolonged treatment. In our case, the patient had thorn prick injury at the site following which the lesions appeared. The reported patients were either adult or elderly patients and majority were immunosuppressed. Our case was a child and there are countable reports of botryomycosis in child. Treatment of botryomycosis is usually prolonged duration of antibiotic. Most often more than one antibiotic is used. However, appropriate antibiotics in combination with surgical excision is the most effective therapy for botryomycosis.[3]

Our case had botryomycosis involving the whole right foot with causative organism being MSSA. The lesions were completely cured with injectable ceftriaxone sodium as a monotherapy. We report the case for rarity in an immunocompetent child and complete cure with ceftriaxone monotherapy.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given her consent for her images and other clinical information to be reported in the journal. The patient understands that her name and initial will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Bonifaz A, Carrasco E. Botryomycosis. Int J Dermatol 1996;35:381-8.  Back to cited text no. 1
    
2.
Machado CR, Schubach AO, Conceição-Silva F, Quintella LP, Lourenço MC, Carregal E, et al. Botryomycosis. Dermatology. 2005;211:303-4.  Back to cited text no. 2
    
3.
Padilla-Desgarennes C, Vázquez-González D, Bonifaz A. Botryomycosis. Clin Dermatol 2012;30:397-402.  Back to cited text no. 3
    
4.
Bonifaz A, Carrasco E. Botryomycosis. Int J Dermatol. 1996;35:381–8.  Back to cited text no. 4
    
5.
Bersoff-Matcha SJ, Roper CC, Liapis H, Little JR. Primary pulmonary botryomycosis: Case report and review. Clin Infect Dis 1998;26:620-4.  Back to cited text no. 5
    
6.
Vasishta RK, Gupta N, Kakkar N. Botryomycosis–A series of six integumentary or visceral cases from India. Ann Trop Med Parasitol 2004;98:623-9.  Back to cited text no. 6
    
7.
Saadat P, Ram R, Sohrabian S, Vadmal MS. Botryomycosis caused by Staphylococcus aureus and Pneumocystis carinii in a patient with acquired immunodeficiency disease. Clin Exp Dermatol 2008;33:266-9.  Back to cited text no. 7
    
8.
Follows GA, Mathew J, Lucas S, Black MJ, Goodship TH. Cutaneous botryomycosis in a patient with lupus nephritis. Nephrol Dial Transplant 1998;13:3200-1.  Back to cited text no. 8
    
9.
Akiyama H, Kanzaki H, Tada J, Arata J. Staphylococcus aureus infection on cut wounds in the mouse skin: Experimental staphylococcal botryomycosis. J Dermatol Sci 1996;11:234-8.  Back to cited text no. 9
    


    Figures

  [Figure 1], [Figure 2], [Figure 3]



 

Top
Print this article  Email this article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow